Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 18;13(1 Suppl):185S–196S. doi: 10.1177/1947603520906597

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Effect of placebo injection. The results of the meta-analysis in terms of VAS pain (0-100), WOMAC-pain (0-20), WOMAC-stiffness (0-8), and WOMAC-function (0-68) at the different follow-ups (1 month, 3 months, 6 months) are compared to the previously reported MCID. Every quadrant reports data about one of the evaluated outcomes whereas axes report the related scale: VAS pain (upper right), WOMAC-pain (bottom right), WOMAC-stiffness (bottom left), and WOMAC function (upper left). The level of the documented improvement is represented by the colored area (red for VAS pain, blue for WOMAC pain, yellow for WOMAC stiffness, green for WOMAC function), whereas the level of the central gray area represents the previously reported MCID for each outcome. All the improvements at all the follow-ups go beyond the previously reported MCID, except for VAS-pain at the 6-month follow-up.